Glen B Baker Selected Research

Dextroamphetamine (Dexedrine)

5/2014	Amphetamine-induced dopamine release and neurocognitive function in treatment-naive adults with ADHD.
6/2003	Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Glen B Baker Research Topics

Disease

22	Schizophrenia (Dementia Praecox) 01/2019 - 08/2008
11	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 09/2010
6	Multiple Sclerosis 01/2022 - 08/2011
6	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2018 - 08/2011
5	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 08/2003
5	Mental Disorders (Mental Disorder) 01/2019 - 03/2004
4	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 08/2008
4	Treatment-Resistant Schizophrenia 01/2021 - 04/2013
4	Neuroinflammatory Diseases 10/2017 - 09/2011
4	Nervous System Diseases (Neurological Disorders) 10/2017 - 09/2004
4	Parkinson Disease (Parkinson's Disease) 08/2015 - 11/2005
4	Cardiovascular Diseases (Cardiovascular Disease) 07/2013 - 08/2003
3	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 01/2014
3	Acquired Immunodeficiency Syndrome (AIDS) 10/2017 - 02/2013
3	Panic Disorder (Panic Attack) 02/2017 - 01/2002
3	Anxiety Disorders (Anxiety Disorder) 08/2014 - 05/2002
2	Treatment-Resistant Depressive Disorder 07/2022 - 01/2020
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 10/2018
2	Dementia (Dementias) 01/2021 - 01/2013
2	Inflammation (Inflammations) 01/2021 - 02/2013
2	Cognitive Dysfunction 01/2021 - 01/2019
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2017 - 05/2014
2	Neurobehavioral Manifestations 01/2017 - 08/2008
2	Infections 08/2014 - 04/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2013 - 01/2012
2	Memory Disorders (Memory Loss) 01/2013 - 06/2009
1	Migraine with Aura (Familial Hemiplegic Migraine) 11/2023
1	Chronic Pain 11/2023
1	Epilepsy (Aura) 11/2023
1	Migraine Disorders (Migraine) 11/2023
1	Stroke (Strokes) 01/2022
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 08/2020
1	Autoimmune Diseases of the Nervous System 08/2020
1	Encephalitis (Encephalitis, Rasmussen) 08/2020
1	Glioma (Gliomas) 08/2020
1	Wounds and Injuries (Trauma) 07/2020

Drug/Important Bio-Agent (IBA)

9	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 07/2022 - 01/2002
9	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 08/2008
9	Monoamine Oxidase (MAO)IBA 01/2018 - 09/2004
8	EnzymesIBA 01/2019 - 09/2009
7	Glutamic Acid (Glutamate)FDA Link 01/2021 - 07/2012
7	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 05/2003
6	Phenelzine (Nardil)FDA Link 07/2022 - 01/2002
6	Serine (L-Serine)FDA Link 01/2021 - 09/2009
6	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 08/2020 - 09/2009
6	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 01/2017 - 07/2013
5	NeurosteroidsIBA 10/2018 - 05/2002
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2012 - 08/2003
4	Amyloid (Amyloid Fibrils)IBA 01/2019 - 01/2013
4	Peptides (Polypeptides)IBA 01/2019 - 01/2013
4	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 08/2008
3	Clozapine (Clozaril)FDA LinkGeneric 01/2021 - 04/2013
3	N-Methylaspartate (NMDA)IBA 01/2021 - 10/2018
3	Aminobutyrates (Aminobutyric Acid)IBA 01/2021 - 06/2013
3	serine racemaseIBA 01/2021 - 09/2009
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2011
3	Proteins (Proteins, Gene)FDA Link 08/2020 - 09/2011
3	Ketamine FDA LinkGeneric 01/2020 - 10/2012
3	Serotonin (5 Hydroxytryptamine)IBA 01/2018 - 01/2014
3	Amino Acids FDA Link 01/2017 - 12/2006
3	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2017 - 01/2009
3	Amphetamine (Amfetamine)FDA LinkGeneric 07/2014 - 08/2008
2	Pregabalin (Lyrica)FDA Link 11/2023 - 10/2012
2	AcidsIBA 01/2022 - 08/2020
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 05/2003
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2019 - 12/2003
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 06/2009
2	Dehydroepiandrosterone (DHEA)IBA 10/2017 - 02/2013
2	Tryptophan (L-Tryptophan)FDA Link 01/2017 - 01/2014
2	Neuroprotective AgentsIBA 02/2015 - 01/2014
2	Minocycline (Cyclops)FDA LinkGeneric 02/2015 - 04/2010
2	RacloprideIBA 07/2014 - 05/2014
2	Dextroamphetamine (Dexedrine)FDA LinkGeneric 05/2014 - 06/2003
2	Pregnanolone (Allopregnanolone)IBA 01/2014 - 09/2011
2	Neurotransmitter Agents (Neurotransmitter)IBA 09/2013 - 01/2013
2	Oxidoreductases (Dehydrogenase)IBA 07/2013 - 06/2013
2	Selegiline (E250)FDA LinkGeneric 07/2013 - 11/2005
2	AminesIBA 07/2013 - 06/2013
2	Phencyclidine (Angel Dust)IBA 07/2012 - 08/2008
2	Paroxetine (Paxil)FDA LinkGeneric 12/2003 - 08/2003
1	voltage-dependent calcium channel (P-Q type)IBA 11/2023
1	Calcium Channels (Calcium Channel)IBA 11/2023
1	Q-Type Calcium Channels (Q-Type Calcium Channel)IBA 11/2023
1	Tranylcypromine (Parnate)FDA LinkGeneric 07/2022
1	Isocarboxazid FDA Link 07/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	OrnithineIBA 01/2022
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2022
1	Nerve Growth Factors (Neurotrophins)IBA 01/2021
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2021
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 08/2020
1	GABA-B ReceptorsIBA 08/2020
1	AntibodiesIBA 08/2020
1	Leucine (L-Leucine)FDA Link 08/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2020
1	AMPA Receptors (AMPA Receptor)IBA 08/2020
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 08/2020

Therapy/Procedure

9	Therapeutics 01/2021 - 12/2010
1	Immunotherapy 08/2020
1	Ketogenic Diet 07/2020